Abstract:C1q/tumor necrosis factor‐related protein 3 (CTRP3) expression is markedly reduced in the serum of patients with osteoporosis. The present study aimed to investigate whether CTRP3 reduces bone loss in oophorectomy (OVX)‐induced mice via the AMP‐activated protein kinase (AMPK)/sirtuin 1 (SIRT1)/nuclear factor E2‐related factor 2 (Nrf2) signaling pathway. Female C57BL/6J mice and MC3T3‐E1 cells were used to construct in vivo and in vitro models of osteoporosis, respectively. The left femurs of mice were examined using micro‐computed tomography scans and bone‐related quantitative morphological evaluation was performed. Pathological changes and the number of osteoclasts in the left femurs of mice were detected using hematoxylin and eosin, and tartrate‐resistant acid phosphatase (TRAP) staining. Runt‐related transcription factor‐2 (RUNX2) expression in the left femurs was detected using immunofluorescence analysis, and the serum levels of bone resorption markers (C‐telopeptide of type I collagen and TRAP) and bone formation markers [osteocalcin (OCN) and procollagen type 1 N‐terminal propeptide] were detected. In addition, osteoblast differentiation and calcium deposits were examined in MC3T3‐E1 cells using alkaline phosphatase (ALP) and Alizarin red staining, respectively. Moreover, RUNX2 , ALP and OCN expression levels were detected using reverse transcription‐quantitative PCR, and the expression levels of proteins associated with the AMPK/SIRT1/Nrf2 signaling pathway were detected using western blot analysis. The results revealed that globular CTRP3 (gCTRP3) alleviated bone loss and promoted bone formation in OVX‐induced mice. gCTRP3 also facilitated the osteogenic differentiation of MC3T3‐E1 cells through the AMPK/SIRT1/Nrf2 signaling pathway. The addition of an AMPK inhibitor (Compound C), SIRT1 inhibitor (EX527) or Nrf2 inhibitor (ML385) reduced the osteogenic differentiation of MC3T3‐E1 cells via inhibition of gCTRP3. In conclusion, gCTRP3 inhibits OVX‐induced osteoporosis by activating the AMPK/SIRT1/Nrf2 signaling pathway.

Tricin protects rats from ovariectomized-induced osteoporosis by enhancing Wnt/β-catenin pathway

Alpinetin Inhibits RANKL-Induced Osteoclastogenesis and Ovariectomy-Induced Bone Loss by Modulating NFATc1 Transcription and Lysosomal Function

A Novel Anti-Osteoporotic Agent That Protects Against Postmenopausal Bone Loss by Regulating Bone Formation and Bone Resorption.

Tricetin Protects Rat Chondrocytes Against IL-1β-Induced Inflammation and Apoptosis

Treadmill Exercise Can Significantly Improve Bone Metabolism in Osteoporosis

Ginsenoside Rc alleviates osteoporosis by the TGF-β/Smad signaling pathway

Trifolirhizin protects ovariectomy-induced bone loss in mice by inhibiting osteoclast differentiation and bone resorption

Tectoridin Inhibits Osteoclastogenesis and Bone Loss in a Murine Model of Ovariectomy-Induced Osteoporosis

Ginsenoside Rc Promotes Bone Formation in Ovariectomy-Induced Osteoporosis In Vivo and Osteogenic Differentiation In Vitro

Beneficial Effect of Pristimerin Against the Development of Osteoporosis in Ovariectomy-Induced Osteoporosis Rats by the RANKL/TRAF6/NF-κB Pathway.

gCTRP3 inhibits oophorectomy‐induced osteoporosis by activating the AMPK/SIRT1/Nrf2 signaling pathway in mice

Matrine Prevents Bone Loss in Ovariectomized Mice by Inhibiting RANKL-induced Osteoclastogenesis

Tectorigenin inhibits RANKL-induced osteoclastogenesis via suppression of NF-κB signalling and decreases bone loss in ovariectomized C57BL/6.

Trim21 depletion alleviates bone loss in osteoporosis via activation of YAP1/-catenin signaling

Preventive and Therapeutic Effect of Corn Cervi Pantotrichum on Bone Tissue in Ovariectomized Rats Through Activation of BMP-2 / Smads / Runx 2 Signal Transduction Pathway

Trim21 depletion alleviates bone loss in osteoporosis via activation of YAP1/β-catenin signaling

Myricitrin promotes osteogenesis and prevents ovariectomy bone mass loss via the PI3K/AKT signalling pathway

TRIM65 Promotes Osteogenic Differentiation by Regulating the PI3K/AKT Signaling Pathway

[Effects of 1 Alpha(oh)d3 on Trabecular and Cortical Bone in Ovariectomized Rats].

Tanshinone I attenuates estrogen-deficiency bone loss via inhibiting RANKL-induced MAPK and NF-κB signaling pathways

Radix Salviae Miltiorrhizae Improves Bone Microstructure and Strength Through Wnt/β‐catenin and Osteoprotegerin/receptor Activator for Nuclear Factor‐κb Ligand/cathepsin K Signaling in Ovariectomized Rats